Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996410 · ClinicalTrials.gov registry record · NA
The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01996410 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 10 participants.
The verdict
NCT01996410, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this study is to determine if acupuncture improves multiple symptoms associated with chemotherapy on the MD Anderson Symptom Inventory (MDASI): nausea, vomiting, fatigue, anxiety, anorexia, pain, disturbed sleep, shortness of breath, dry mouth, depression, and peripheral neuropathy (see statistical section). The investigators hypothesis is that acupuncture will result in lower MDASI scores over the course of chemotherapy for the acupuncture group vs. control group.
Interventions
- DEVICE Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01996410
The ClinicalTrials.gov registry entry for NCT01996410 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.
NCT01996410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01996410 about?
NCT01996410 is a clinical study titled "The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients". The goal of this study is to determine if acupuncture improves multiple symptoms associated with chemotherapy on the MD Anderson Symptom Inventory (MDASI): nausea, vomiting, fatigue, anxiety, anorexia, pain, disturbed sleep, shortness of breath, dry mouth, depression, and peripheral neuropathy (see ...
What is the current status of trial NCT01996410?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2013-11. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01996410?
The interventions under investigation include: Acupuncture (DEVICE).
Who is sponsoring clinical trial NCT01996410?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.